These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5756318)

  • 21. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
    Cossu G; Melis M; Melis G; Maccioni E; Putzu V; Catte O; Putzu PF
    Mov Disord; 2004 Oct; 19(10):1243-4. PubMed ID: 15389998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Galantamine therapy in dementia associated with CADASIL].
    Posada IJ; Ferrero M; Lopez-Valdes E; Goni-Imizcoz M
    Rev Neurol; 2008 Sep 16-30; 47(6):299-300. PubMed ID: 18803156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galantamine (reminyl) for Alzheimer's disease.
    Med Lett Drugs Ther; 2001 Jun; 43(1107):53-4. PubMed ID: 11426189
    [No Abstract]   [Full Text] [Related]  

  • 25. Galantamine treatment of cognitive impairment in bipolar disorder: four cases.
    Schrauwen E; Ghaemi SN
    Bipolar Disord; 2006 Apr; 8(2):196-9. PubMed ID: 16542191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.
    López-Pousa S; Olmo JG; Franch JV; Estrada AT; Cors OS; Nierga IP; Gelada-Batlle E
    Age Ageing; 2006 Jul; 35(4):365-71. PubMed ID: 16788079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galantamine: excess mortality.
    Prescrire Int; 2005 Jun; 14(77):103. PubMed ID: 15986514
    [No Abstract]   [Full Text] [Related]  

  • 28. [Complete atrioventricular block during galantamine therapy].
    Schölzel-Dorenbos CJ
    Ned Tijdschr Geneeskd; 2006 Apr; 150(17):989-90; author reply 990. PubMed ID: 17225744
    [No Abstract]   [Full Text] [Related]  

  • 29. Galantamine: use in Alzheimer's disease and related disorders.
    Bullock R
    Expert Rev Neurother; 2004 Mar; 4(2):153-63. PubMed ID: 15853556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching from donepezil to galantamine: a double-blind study of two wash-out periods.
    Wilkinson DG; Howe I
    Int J Geriatr Psychiatry; 2005 May; 20(5):489-91. PubMed ID: 15852437
    [No Abstract]   [Full Text] [Related]  

  • 31. Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels.
    Zhang HX; Zhang W; Jin HW; Wang XL
    Brain Res Mol Brain Res; 2004 Nov; 131(1-2):136-40. PubMed ID: 15530663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
    Aarsland D; Hutchinson M; Larsen JP
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):937-41. PubMed ID: 14533126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An innovative approach to involve patients in measuring treatment effects in drug trials.
    Kaduszkiewicz H
    CMAJ; 2006 Apr; 174(8):1117-8. PubMed ID: 16554497
    [No Abstract]   [Full Text] [Related]  

  • 34. Galantamine: a review of its use in Alzheimer's disease and vascular dementia.
    Corey-Bloom J
    Int J Clin Pract; 2003 Apr; 57(3):219-23. PubMed ID: 12723727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of journal advertisements on prescribers of cholinesterase inhibitors.
    Sauer J; Howard R
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):976-8. PubMed ID: 12325061
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of the antagonism toward d-tubucurarine of a new cholinesterase inhibitor (Nivaline)].
    SALVINI L; FROSALI L; PACETTI AM
    Minerva Anestesiol; 1962 May; 28():201-4. PubMed ID: 14496519
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anticurarizing action of Nivaline].
    PASKOV D; STOYANOV K; SAEV S; DEREDJIAN A; KRASTEVA E; TENEV K; MINTCHEVA M
    Minerva Anestesiol; 1962 Jun; 28():213-9. PubMed ID: 14484181
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of galantamine bromhydrate (nivaline) in the paralytic sequelae of poliomyelitis, neuraxitis and in muscular dystrophy].
    LOMBARDO G; ARENA G
    Minerva Pediatr; 1962 Jun; 14():724-8. PubMed ID: 14466410
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nivaline].
    MARMO E
    Riforma Med; 1961 Mar; 75():339-40. PubMed ID: 13767009
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nivaline. Toxicological study in relation to the possibilities of direct injection into the blood circulation].
    FRACCHIOLLA V; MICHELETTI A
    Gazz Med Ital; 1962 Feb; 121():49-50. PubMed ID: 13894420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.